by Virtus | Aug 5, 2026 | Respiratory Preclinical Research
Proof of concept studies are a critical milestone in respiratory drug development. Before a therapeutic candidate progresses into large-scale preclinical programmes or clinical trials, researchers need evidence that it produces the intended biological effect. Proof of...
by Virtus | Aug 5, 2026 | Respiratory Preclinical Research
Preclinical efficacy testing is one of the most important stages of respiratory drug development. Before a new therapeutic candidate progresses into clinical trials, researchers must demonstrate that it produces meaningful biological effects within carefully designed...
by Virtus | Jun 28, 2026 | Respiratory Preclinical Research
Respiratory biomarkers have become one of the most valuable tools in modern respiratory drug development. They provide measurable biological indicators that help researchers understand disease progression, evaluate therapeutic responses and improve decision-making...
by Virtus | Jun 28, 2026 | Respiratory Preclinical Research
Translational respiratory research is one of the most important stages in modern respiratory drug development. While preclinical respiratory research provides valuable insight into disease biology and therapeutic efficacy, translational research ensures that these...
by Virtus | Jun 6, 2026 | Respiratory Preclinical Research
Respiratory disease models are essential tools in preclinical respiratory research, allowing scientists to investigate disease mechanisms, evaluate therapeutic candidates and generate data that supports respiratory drug development. From asthma and COPD to viral...
by Virtus | Jun 6, 2026 | Respiratory Preclinical Research
Preclinical respiratory models play a vital role in respiratory drug development by allowing researchers to evaluate therapeutic candidates before clinical trials begin. These models are used throughout respiratory preclinical research to investigate disease...